CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapy

J. Dawn Waters, Carlos Sanchez, Ayguen Sahin, Diahnn Futalan, David D. Gonda, Justin K. Scheer, Johnny Akers, Kamalakannan Palanichamy, Peter Waterman, Arnab Chakravarti, Ralph Weissleder, Brent Morse, Nick Marsh, Eric Furfine, Clark C. Chen, Irvith Carvajal, Bob S. Carter

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapy'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience